Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Apr 18;49(2):531-537.
doi: 10.3906/sag-1808-130.

Glutamate transporter SLC1A1 is associated with clear cell renal cell carcinoma

Sercan Ergün, Sezgin Güneş, Recep Büyükalpelli, Oğuz Aydın
Comparative Study

Glutamate transporter SLC1A1 is associated with clear cell renal cell carcinoma

Sercan Ergün et al. Turk J Med Sci. .

Abstract

Background/aim: This study aimed to comparatively analyze the expression levels of the SLC1A1 gene in renal specimens from tumors and adjacent healthy kidney tissues of patients with clear cell renal cell carcinoma (ccRCC).

Materials and methods: Nineteen patients diagnosed with ccRCC were included in the study. The expression levels of the SLC1A1 and GAPDH genes were measured in tumor and formalin-fixed paraffin-embedded (FFPE) tissue specimens from the adjacent healthy kidney of each subject. Via the GEPIA database, the distribution of SLC1A1 gene expressions in ccRCC and healthy kidney tissues was obtained. The relative expression of SLC1A1 was evaluated for the association with the clinical parameters of the patients.

Results: The expression of the SLC1A1 gene was significantly higher in males than females (P = 0.029). Also, there were statistically significant associations between stages II–IV and Fuhrman grades 2–4 with respect to SLC1A1 gene expression (P < 0.001 for both). Moreover, low levels of red blood cell and hemoglobin counts were significantly associated with the SLC1A1 expression (P < 0.001 and P = 0.005, respectively). The expression of the SLC1A1 gene in tumor tissues increased approximately 3 times compared with normal kidney tissues (P < 0.05). According to the GEPIA database, SLC1A1 gene expression is significantly higher in ccRCC patients than healthy persons (P = 0.01).

Conclusion: The change in the expression of SLC1A1 may be crucial for ccRCC pathophysiology.

Keywords: Glutamate transporter; SLC1A1; oncogene; renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST:

none declared

Figures

Figure 1
Figure 1
Quantitative expression levels of the SLC1A1 gene in tumor tissues as compared with adjacent healthy kidney tissues of patients with ccRCC (P < 0.05).
Figure 2
Figure 2
Distribution of patients’ quantitative expression levels of the SLC1A1 gene in tumor tissues as compared to adjacent healthy kidney tissues.
Figure 3
Figure 3
Distribution of SLC1A1 gene expressions in ccRCC and healthy kidney tissues according to TCGA normal and GTEx data in GEPIA database (P = 0.01).
See this image and copyright information in PMC

References

    1. Shingarev R Jaimes EA Renal cell carcinoma: new insights and challenges for a clinician scientist. Am J Physiol-Renal. 2017;313:F145. - PMC - PubMed
    1. Parker WP Cheville JC Frank I Zaid HB Lohse CM Boorjian SA Leibovich BC Thompson RH Application of the stage, size, grade, and necrosis (SSIGN) score for clear cell renal cell carcinoma in contemporary patients. 2017;71:665. - PMC - PubMed
    1. Soultati A Stares M Swanton C Larkin J Turajlic S. How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma? Curr Opin Urol . 2015;25:358. - PubMed
    1. Muglia VF Prando A Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras. 2015;48:166. - PMC - PubMed
    1. Xing T He H Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology. Chinese J Cancer Res. 2016;28:80–80. - PMC - PubMed

Publication types

Substances